VETRANO, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 3.021
AS - Asia 1.315
EU - Europa 645
SA - Sud America 483
AF - Africa 100
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 5.570
Nazione #
US - Stati Uniti d'America 2.957
SG - Singapore 743
BR - Brasile 427
CN - Cina 290
FI - Finlandia 158
VN - Vietnam 101
IT - Italia 93
DE - Germania 83
IE - Irlanda 79
NG - Nigeria 68
FR - Francia 52
SE - Svezia 38
CA - Canada 36
HK - Hong Kong 36
IN - India 36
NL - Olanda 31
GB - Regno Unito 30
AR - Argentina 17
EC - Ecuador 14
MX - Messico 14
TR - Turchia 14
BD - Bangladesh 13
BE - Belgio 13
JP - Giappone 13
RU - Federazione Russa 13
IL - Israele 11
ZA - Sudafrica 11
ID - Indonesia 10
PL - Polonia 10
ES - Italia 8
IQ - Iraq 7
PY - Paraguay 7
PK - Pakistan 6
UA - Ucraina 6
CL - Cile 5
DO - Repubblica Dominicana 5
MA - Marocco 5
SA - Arabia Saudita 5
VE - Venezuela 5
CO - Colombia 4
EG - Egitto 4
KG - Kirghizistan 4
LT - Lituania 4
RO - Romania 4
CZ - Repubblica Ceca 3
DZ - Algeria 3
JM - Giamaica 3
KZ - Kazakistan 3
TN - Tunisia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AT - Austria 2
AU - Australia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
EE - Estonia 2
GE - Georgia 2
HN - Honduras 2
IR - Iran 2
JO - Giordania 2
KE - Kenya 2
LB - Libano 2
MD - Moldavia 2
NO - Norvegia 2
NP - Nepal 2
PE - Perù 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CY - Cipro 1
DK - Danimarca 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
MK - Macedonia 1
MU - Mauritius 1
MY - Malesia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TO - Tonga 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 5.570
Città #
Wilmington 429
Chandler 388
Singapore 287
Dallas 207
The Dalles 201
Ashburn 170
Helsinki 156
San Mateo 145
Shanghai 141
Ann Arbor 128
Boardman 96
Beijing 91
Leawood 81
Dublin 79
Lawrence 77
Princeton 77
Benin City 68
New York 55
Paris 51
Ho Chi Minh City 44
Fairfield 39
Woodbridge 37
Hong Kong 36
Los Angeles 29
Milan 29
Amsterdam 28
São Paulo 27
Toronto 26
Hanoi 23
Seattle 23
Abbiategrasso 21
Columbus 19
Council Bluffs 19
Pune 16
London 14
Naples 14
Phoenix 14
Brussels 13
Chicago 12
Munich 12
Rio de Janeiro 12
Curitiba 11
Belo Horizonte 10
Norwalk 10
Santa Clara 10
Warsaw 10
Brooklyn 9
Brasília 8
Frankfurt am Main 8
Porto Alegre 8
San Francisco 8
Boston 7
San Diego 7
Tokyo 7
Assago 6
Denver 6
Guayaquil 6
Houston 6
Kocaeli 6
Atlanta 5
Campinas 5
Charlotte 5
Duque de Caxias 5
Bishkek 4
Feira de Santana 4
Fortaleza 4
Jakarta 4
Johannesburg 4
Mexico City 4
Monmouth Junction 4
Ribeirão Preto 4
São José 4
Volta Redonda 4
Alexandria 3
Asunción 3
Betim 3
Blumenau 3
Catanduva 3
Charleston 3
Chengdu 3
Chennai 3
Ciudad del Este 3
Da Nang 3
Dracena 3
Falkenstein 3
Falls Church 3
Giussano 3
Gunzenhausen 3
Hangzhou 3
Hải Dương 3
Irkutsk 3
Kingston 3
Manaus 3
Montreal 3
Mumbai 3
Newark 3
Nova Friburgo 3
Osaka 3
Osasco 3
Quito 3
Totale 3.718
Nome #
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 130
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response 126
The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation 110
Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease 97
Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease 97
Colitis-associated cancer: the dark side of inflammatory bowel disease 94
New insights into inflammatory bowel disease pathophysiology: Paving the way for novel therapeutic targets 92
Colifagina, a novel preparation of 8 lysed bacteria ameliorates experimental colitis 91
Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study 91
VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis 85
Protumor Steering of Cancer Inflammation by p50 NF-κB Enhances Colorectal Cancer Progression 85
mTOR-Dependent Stimulation of IL20RA Orchestrates Immune Cell Trafficking through Lymphatic Endothelium in Patients with Crohn's Disease 83
Effect of Immunosuppression on Immune Response to Pneumococcal Vaccine in Inflammatory Bowel Disease: A Prospective Study 81
VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease 80
Centrally Determined Standardization of Flow Cytometry Methods Reduces Interlaboratory Variation in a Prospective Multicenter Study 77
The bacterial sensor Triggering Receptor Expressed on Myeloid cells 2 (TREM-2) is a crucial pathogenic mediator in inflammatory bowel disease (IBD) 77
Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease 77
Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease 76
MFSD2A Promotes Endothelial Generation of Inflammation-resolving Lipid Mediators and Reduces Colitis in Mice 75
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease : a prospective study 75
Contrast-enhancement at magnetic resonance enterography does not differentiate between fibrosis and inflammation in Crohn's disease: a prospective cohort study 74
Colitis, microbiota and colon cancer: an infernal triangle 74
Enhanced platelet adhesion induces angiogenesis in intestinal inflammation and inflammatory bowel disease microvasculature 73
Effect of Tumor Necrosis Factor-alpha Blockade on Mucosal Addressin Cell-adhesion Molecule-1 in Crohn's Disease 70
Cathelicidins: A Novel Therapy for the Treatment of Intestinal Fibrosis 70
Anti-TNF Antibodies and Autophagy: A Hidden Nexus for a Successful Therapeutic Response? 69
Antiendomysial antibody detection in fecal supernatants: In vivo proof that small bowel mucosa is the site of antiendomysial antibody production 68
Detection of anti-endomysial and anti-tissue transglutaminase autoantibodies in media following culture of oral biopsies from patients with untreated coeliac disease 68
Infliximab Inhibits Mucosal Pathological Angiogenesis in Crohn's Disease 67
A Small CEACAM5 Peptide Restores the Protective Function of CD8+ Regulatory T Cells in Crohn's Disease 66
Mesenchymal Stem Cells to Treat Digestive System Disorders: Progress Made and Future Directions 66
RISK OF MICROBIAL TRANSLOCATION IN PATIENTS UNDERGOING PER-ORAL ENDOSCOPIC MYOTOMY FOR ACHALASIA. PRELIMINARY RESULTS 66
OP018 High-fat diet and inflammation drive intestinal fibrosis enhancing epithelial–mesenchymal transition through the activation of S1P3 signalling 66
JAK-STAT Pathway Targeting for the Treatment of Inflammatory Bowel Disease 66
Multiple pathogenic roles of microvasculature in inflammatory bowel disease : a Jack of all trades 65
The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications 64
Unexpected role of anticoagulant protein C in controlling epithelial barrier integrity and intestinal inflammation. 64
Mesenchymal stromal cells in inflammatory bowel disease: conspirators within the 'colitogenic niche'? 63
NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high antitumor activity against colorectal cancer 63
The Multiple Faces of Integrin-ECM Interactions in Inflammatory Bowel Disease 63
Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease 62
Anti-endomysial antibody of IgG1 isotype detection strongly increases the prevalence of coeliac disease in patients affected by type I diabetes mellitus 62
Targeting S1P in Inflammatory Bowel Disease: New Avenues for Modulating Intestinal Leukocyte Migration 61
The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease 61
STIMULATION OF CYP450-MEDIATED omega-3 DOCOSAHEXAENOIC ACID (DHA) METABOLISM VIA MFSD2A AS A NOVEL THERAPY FOR INFLAMMATORY BOWEL DISEASE 61
Lymphatic endothelium contributes to colorectal cancer growth via the soluble matrisome component GDF11 61
The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity. 60
Involvement of CD40-CD40 Ligand in Uncomplicated and Refractory Celiac Disease 60
Rho-A prenylation and signaling link epithelial homeostasis to intestinal inflammation 59
Sealing the broken barrier in IBD: intestinal permeability, epithelial cells and junctions 59
Stimulation of CYP450-mediated omega-3 docosahexaenoic acid metabolism via MFSD2A as a novel therapy for inflammatory bowel disease 59
The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6 58
Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease 57
Unveiling role of sphingosine-1-phosphate receptor 2 as a brake of epithelial stem cell proliferation and a tumor suppressor in colorectal cancer 57
The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges 57
The Role of JAM-A in Inflammatory Bowel Disease: Unrevealing the Ties That Bind 56
Usefulness of the organ culture system in the in vitro diagnosis of coeliac disease: A multicentre study 56
Dysfunctional Extracellular Matrix Remodeling Supports Perianal Fistulizing Crohn's Disease by a Mechanoregulated Activation of the Epithelial-to-Mesenchymal Transition 55
Intestinal myofibroblast-specific Tpl2-Cox-2-PGE(2) pathway links innate sensing to epithelial homeostasis 54
The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6 54
Journey through Crohn's Disease Complication: From Fistula Formation to Future Therapies 54
TNF-stimulated gene-6 (TSG-6) is a key regulator in switching stemness and biological properties of mesenchymal stem cells 53
Single-dose versus short-course prophylactic antibiotics for peroral endoscopic myotomy: a randomized controlled trial 53
Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine 52
The atypical chemokine receptor D6 controls intestinal inflammation and inflammation-associated colon cancer 52
Stimulation of CYP450-mediated ω-3 docosahexaenoic acid metabolism via MFSD2A as a novel therapy for inflammatory bowel disease 51
Antiendomysial Antibody Detection in Biopsy Culture Allows Avoidance of Gluten Challenge in Celiac Children 49
The protein C pathway in intestinal barrier function: challenging the hemostasis paradigm 49
Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer 49
Dynamic changes in extracellular vesicle-associated miRNAs elicited by ultrasound in inflammatory bowel disease patients 48
Mesenchymal Stem Cells in IBD: unMaSCing Their Therapeutic Mechanisms 48
Hyaluronan Accelerates Intestinal Mucosal Healing through Interaction with TSG-6 48
Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017 47
Tumor-associated macrophages and risk of recurrence in stage III colorectal cancer 47
GPR120 prevents colorectal adenocarcinoma progression by sustaining the mucosal barrier integrity 47
In vitro Anti-inflammatory and Protective Effects of ibidì® on Intestinal Epithelial Cells 46
Programming of Intestinal Epithelial Differentiation by IL-33 Derived from Pericryptal Fibroblasts in Response to Systemic Infection 45
Endothelial Tpl2 regulates vascular barrier function via JNK-mediated degradation of claudin-5 promoting neuroinflammation or tumor metastasis 45
Reciprocal influence of B cells and tumor macro and microenvironments in the ApcMin/+ model of colorectal cancer 44
Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel 43
Anti-Tissue Transglutaminase Antibodies in Arthritic Patients: A Disease-specific Finding? 40
Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor 38
ImmUniverse Consortium: Multi-omics integrative approach in personalized medicine for immune-mediated inflammatory diseases 37
Pomegranate Extract Affects Gut Biofilm Forming Bacteria and Promotes Intestinal Mucosal Healing Regulating the Crosstalk between Epithelial Cells and Intestinal Fibroblasts 37
The Inflammatory Bowel Disease Transcriptome and Metatranscriptome Meta-Analysis (IBD TaMMA) framework 35
Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease 33
Forty-Eight Hours of Biopsy Culture Improve the Sensitivity of the in Vitro Gliadin Challenge in the Diagnosis of Celiac Disease 29
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference 29
Mesalamine in the treatment of mild to moderate active Crohn's ileitis: Results of a randomized, multicenter trial 28
Sphingosine 1-Phosphate Modulation in Inflammatory Bowel Diseases: Keeping Lymphocytes Out of the Intestine 28
Fibrotic Strictures in Crohn’s Disease: Mechanisms and Predictive Factors 28
Fibro-Stenosing Crohn’s Disease: What Is New and What Is Next? 19
Totale 5.664
Categoria #
all - tutte 41.006
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.006


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021744 0 0 0 0 0 244 117 45 162 84 2 90
2021/2022455 27 3 8 77 4 2 12 54 41 38 157 32
2022/20231.103 182 65 96 118 107 85 3 76 184 104 67 16
2023/2024732 57 72 125 72 34 111 32 22 12 19 53 123
2024/20251.226 27 16 7 54 27 139 93 136 159 268 141 159
2025/20261.343 433 210 270 286 122 22 0 0 0 0 0 0
Totale 5.664